| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ZS PHARMA INC | 50,000 | 1,962,000 | 0.40% | ||
| 52 | ALDER BIOPHARMACEUTICALS INC | 150,000 | 1,902,000 | 0.39% | ||
| 53 | CERULEAN PHARMA INC | 450,000 | 1,899,000 | 0.39% | ||
| 54 | CELSUS THERAPEUTICS PLC | 244,500 | 1,491,000 | 0.31% | ||
| 55 | REGULUS THERAPEUTICS INC COM | 200,000 | 1,366,000 | 0.28% | ||
| 56 | Cellectar Biosciences @4.68 8/ | 530,000 | 1,177,000 | 0.24% | ||
| 57 | ADVAXIS INC COM NEW | 350,000 | 1,176,000 | 0.24% | ||
| 58 | APPLIED GENETIC TECHNOL CORP | 60,600 | 1,128,000 | 0.23% | ||
| 59 | Agile Therapeutics, Inc. | 150,000 | 1,095,000 | 0.23% | ||
| 60 | MINERVA NEUROSCIENCES INC COM | 175,000 | 1,059,000 | 0.22% | ||
| 61 | BRISTOL MYERS SQUIBB CO | 5,000 | 985,000 | 0.20% | ||
| 62 | Curis, Inc | 600,000 | 846,000 | 0.17% | ||
| 63 | SCYNEXIS INC | 100,000 | 739,000 | 0.15% | ||
| 64 | CELLECTAR BIOSCIENCES INC | 530,000 | 318,000 | 0.07% | ||
| 65 | SAGE THERAPEUTICS INC | 10,000 | 315,000 | 0.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-14-041889, filed 2014.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
